Focus
Immunotherapy Investors: Angels and VC Firms
The RaiseHunt database lists 175 Immunotherapy investors: 32 angel investors and 143 people at 28 firms. Most list Series A and Growth among their stages; the largest hubs are Boston, Cambridge and San Francisco.
Strongest in Boston, Cambridge and San Francisco
- 175
- Immunotherapy investors
- 32
- Angel investors
- 143
- People at VC/PE firms
- 28
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
175 Immunotherapy investors
Showing 81-100
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
NY Naveen Yalamanchi Dean's Leadership Council at UCI Beall Applied Innovation @ the Cove | New York, United States | AcceleratorPrivate equity | AIConsumer | View profile | |
BS Beth Seidenberg Co-founding Managing Director at Westlake BioPartners® | Westlake Village, United States | AcceleratorVenture capital | AIClimate | View profile | |
AS Andy Schwab Founder and Managing Partner at 5AM Ventures | San Francisco, United States | Venture capital | Healthcare | View profile | |
SR Scott Rocklage Founding Partner at 5AM Ventures | Palm Beach Gardens, United States | Venture capital | Healthcare | View profile | |
SP Stella Paffenholz Principal at Nextech Invest | Boston, United States | Venture capital | Healthcare | View profile | |
JV Joseph Victor Venture Advisor at 5AM Ventures | Bellevue, United States | Venture capital | Healthcare | View profile | |
DP Deborah Palestrant Partner at 5AM Ventures | Cambridge, United States | Venture capital | Healthcare | View profile | |
DJ David Jouarisse Venture Partner at Akka Venture | Paris, France | Venture debt | Healthcare | View profile | |
SH Sean H. Principal at Pictet Group | United Kingdom | Fund of fundsPrivate equity | AIHealthcare | View profile | |
AK Adel Khalil Principal at Pictet Group | Geneva, Switzerland | Fund of fundsPrivate equity | AIHealthcare | View profile | |
DG David Grayzel Managing Director at Atlas Venture | Cambridge, United States | Venture capital | CommerceConsumer | View profile | |
SR Steven Robinette Venture Partner at Atlas Venture | Boston, United States | Venture capital | CommerceConsumer | View profile | |
MG Michael Greenberg Vice President at Sanofi | New York City, United States | Corporate VC | AIHealthcare | View profile | |
KB Katie Bodner Spielberg Principal at 5AM Ventures | Boston, United States | Venture capital | Healthcare | View profile | |
ND Neil Deramchi Principal at Tachyon Ventures | United States | Venture capital | AIHealthcare | View profile | |
JM Jodie Morrison Venture Partner/Advisor at Atlas Venture | United States | Venture capital | CommerceConsumer | View profile | |
RV Rathnam Venkat Biotech Investor at 5AM Ventures | United States | Venture capital | Healthcare | View profile | |
NB Niresh Berinpanathan Principal at Nextech Invest | Zürich, Switzerland | Venture capital | Healthcare | View profile | |
DB David Braga Malta Managing Partner at Pictet Group | Switzerland | Fund of fundsPrivate equity | AIHealthcare | View profile | |
ZC Zhaomin Chen Head of Research External Innovation at Sanofi | Shanghai, China | Corporate VC | AIHealthcare | View profile |
Data: RaiseHunt investor dataset · Snapshot 27 August 2026 · How this data is built · Report a correction or request removal